Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
mercoledì, ottobre 28
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Viemed Healthcare Inc
VMD
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$9.97
0.29
3%
Ult. Agg.: Oct 28, 1:17 PM
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
Utili:
I risultati di Q3 2026 tra 7 giorni da adesso in mer nov 4th, dopo la chiusura del mercato
Viemed Healthcare Financials
Viemed Healthcare (VMD) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Viemed Healthcare Raises FY2026 Sales Guidance from $312.000M-$320.000M to $314.000M-$320.000M vs $317.300M Est
Viemed Healthcare (NASDAQ:VMD) raises FY2026 sales outlook from $312.000 million-$320.000 million to $314.000 million-$320.000 million vs $317.300 million estimate.
Benzinga Newsdesk
PRO
Viemed Healthcare Q2 EPS $0.07 Misses $0.12 Estimate, Sales $78.097M Miss $78.100M Estimate
Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.07 per share which missed the analyst consensus estimate of $0.12 by 41.67 percent. This is a 12.5 percent decrease over earnings of $0.08 per share from
Benzinga Newsdesk
PRO
Viemed Healthcare Raises FY2026 Sales Guidance from $310.000M-$320.000M to $312.000M-$320.000M vs $315.450M Est
Viemed Healthcare (NASDAQ:VMD) raises FY2026 sales outlook from $310.000 million-$320.000 million to $312.000 million-$320.000 million vs $315.450 million estimate.
Benzinga Newsdesk
PRO
Viemed Healthcare Q1 EPS $0.06 Misses $0.09 Estimate, Sales $75.414M Beat $74.400M Estimate
Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.09 by 33.33 percent. This is unchanged from the same period last year. The company reported
Benzinga Newsdesk
Earnings Scheduled For May 5, 2026
Benzinga Insights
PRO
Viemed Healthcare Sees FY2026 Sales $310.000M-$320.000M vs $332.550M Est.
Viemed Healthcare (NASDAQ:VMD) sees FY2026 sales of $310.000 million-$320.000 million vs $332.550 million analyst estimate.
Benzinga Newsdesk
